165 related articles for article (PubMed ID: 33890983)
1. High-fat diet-induced activation of SGK1 promotes Alzheimer's disease-associated tau pathology.
Elahi M; Motoi Y; Shimonaka S; Ishida Y; Hioki H; Takanashi M; Ishiguro K; Imai Y; Hattori N
Hum Mol Genet; 2021 Aug; 30(18):1693-1710. PubMed ID: 33890983
[TBL] [Abstract][Full Text] [Related]
2. miR-219-5p inhibits tau phosphorylation by targeting TTBK1 and GSK-3β in Alzheimer's disease.
Li J; Chen W; Yi Y; Tong Q
J Cell Biochem; 2019 Jun; 120(6):9936-9946. PubMed ID: 30556160
[TBL] [Abstract][Full Text] [Related]
3. High-fat diet increases tau expression in the brain of T2DM and AD mice independently of peripheral metabolic status.
Takalo M; Haapasalo A; Martiskainen H; Kurkinen KM; Koivisto H; Miettinen P; Khandelwal VK; Kemppainen S; Kaminska D; Mäkinen P; Leinonen V; Pihlajamäki J; Soininen H; Laakso M; Tanila H; Hiltunen M
J Nutr Biochem; 2014 Jun; 25(6):634-41. PubMed ID: 24746833
[TBL] [Abstract][Full Text] [Related]
4. Serum- and glucocorticoid-inducible kinase 1 (SGK1) increases neurite formation through microtubule depolymerization by SGK1 and by SGK1 phosphorylation of tau.
Yang YC; Lin CH; Lee EH
Mol Cell Biol; 2006 Nov; 26(22):8357-70. PubMed ID: 16982696
[TBL] [Abstract][Full Text] [Related]
5. Serum- and glucocorticoid-induced kinase drives hepatic insulin resistance by directly inhibiting AMP-activated protein kinase.
Zhou B; Zhang Y; Li S; Wu L; Fejes-Toth G; Naray-Fejes-Toth A; Soukas AA
Cell Rep; 2021 Oct; 37(1):109785. PubMed ID: 34610303
[TBL] [Abstract][Full Text] [Related]
6. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.
Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F
Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110
[TBL] [Abstract][Full Text] [Related]
7. SGK1 activation exacerbates diet-induced obesity, metabolic syndrome and hypertension.
Sierra-Ramos C; Velazquez-Garcia S; Vastola-Mascolo A; Hernández G; Faresse N; Alvarez de la Rosa D
J Endocrinol; 2020 Jan; 244(1):149-162. PubMed ID: 31600722
[TBL] [Abstract][Full Text] [Related]
8. High-Fat Diet-Induced Diabetic Conditions Exacerbate Cognitive Impairment in a Mouse Model of Alzheimer's Disease Via a Specific Tau Phosphorylation Pattern.
Ito Y; Takeda S; Nakajima T; Oyama A; Takeshita H; Miki K; Takami Y; Takeya Y; Shimamura M; Rakugi H; Morishita R
J Prev Alzheimers Dis; 2024; 11(1):138-148. PubMed ID: 38230726
[TBL] [Abstract][Full Text] [Related]
9. Insulin upregulates the expression of epithelial sodium channel in vitro and in a mouse model of acute lung injury: role of mTORC2/SGK1 pathway.
He J; Qi D; Wang DX; Deng W; Ye Y; Feng LH; Zhu T; Zhao Y; Zhang CR
Exp Cell Res; 2015 Feb; 331(1):164-175. PubMed ID: 25265063
[TBL] [Abstract][Full Text] [Related]
10. RNA Interference Silencing of Glycogen Synthase Kinase 3β Inhibites Tau Phosphorylation in Mice with Alzheimer Disease.
Bian H; Bian W; Lin X; Ma Z; Chen W; Pu Y
Neurochem Res; 2016 Sep; 41(9):2470-80. PubMed ID: 27255602
[TBL] [Abstract][Full Text] [Related]
11. Interaction Between a High-Fat Diet and Tau Pathology in Mice: Implications for Alzheimer's Disease.
Jang YJ; Choi MG; Yoo BJ; Lee KJ; Jung WB; Kim SG; Park SA
J Alzheimers Dis; 2024; 97(1):485-506. PubMed ID: 38108353
[TBL] [Abstract][Full Text] [Related]
12. The ε3 and ε4 alleles of human APOE differentially affect tau phosphorylation in hyperinsulinemic and pioglitazone treated mice.
To AW; Ribe EM; Chuang TT; Schroeder JE; Lovestone S
PLoS One; 2011 Feb; 6(2):e16991. PubMed ID: 21347323
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of EphB2 attenuates tau phosphorylation through PI3K/Akt-mediated inactivation of glycogen synthase kinase-3β.
Jiang J; Wang ZH; Qu M; Gao D; Liu XP; Zhu LQ; Wang JZ
Sci Rep; 2015 Jun; 5():11765. PubMed ID: 26119563
[TBL] [Abstract][Full Text] [Related]
14. Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology.
Koren-Iton A; Salomon-Zimri S; Smolar A; Shavit-Stein E; Dori A; Chapman J; Michaelson DM
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075060
[TBL] [Abstract][Full Text] [Related]
15. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M
J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
[TBL] [Abstract][Full Text] [Related]
16. Long term high fat diet induces metabolic disorders and aggravates behavioral disorders and cognitive deficits in MAPT P301L transgenic mice.
Xiong J; Deng I; Kelliny S; Lin L; Bobrovskaya L; Zhou XF
Metab Brain Dis; 2022 Aug; 37(6):1941-1957. PubMed ID: 35704147
[TBL] [Abstract][Full Text] [Related]
17. Capsaicin reduces Alzheimer-associated tau changes in the hippocampus of type 2 diabetes rats.
Xu W; Liu J; Ma D; Yuan G; Lu Y; Yang Y
PLoS One; 2017; 12(2):e0172477. PubMed ID: 28225806
[TBL] [Abstract][Full Text] [Related]
18. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1).
García-Martínez JM; Alessi DR
Biochem J; 2008 Dec; 416(3):375-85. PubMed ID: 18925875
[TBL] [Abstract][Full Text] [Related]
19. Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease.
Sharma N; Tramutola A; Lanzillotta C; Arena A; Blarzino C; Cassano T; Butterfield DA; Di Domenico F; Perluigi M; Barone E
Neurobiol Dis; 2019 May; 125():176-189. PubMed ID: 30738142
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA 00507/miRNA-181c-5p/TTBK1/MAPT axis regulates tau hyperphosphorylation in Alzheimer's disease.
Yan Y; Yan H; Teng Y; Wang Q; Yang P; Zhang L; Cheng H; Fu S
J Gene Med; 2020 Dec; 22(12):e3268. PubMed ID: 32891070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
